In vivo T-cell depletion with antithymocyte globulin or alemtuzumab for unrelated donor stem cell transplantation with reduced intensity conditioning: results of a multicentre randomized phase II clinical trial (the Global study) from the GITMO

被引：0

作者：

Algarotti, A. ^{[1
]}

Mico, C. ^{[1
]}

Corradini, P. ^{[2
]}

Falda, M. ^{[3
]}

Alessandrino, E. P. ^{[4
]}

Fanin, R. ^{[5
]}

Tagliaferri, E. ^{[6
]}

Castagna, L. ^{[7
]}

Mordini, N. ^{[8
]}

Sica, S. ^{[9
]}

Santarone, S. ^{[10
]}

Levis, A. ^{[11
]}

Iori, A. ^{[12
]}

Pollichieni, S. ^{[13
]}

Sacchi, N. ^{[13
]}

Scarano, M. ^{[14
]}

Masciulli, A. ^{[14
]}

Marchioli, R. ^{[14
]}

Bacigalupo, A. ^{[15
]}

Bosi, A. ^{[16
]}

Rambaldi, A. ^{[1
]}

机构：

[1] Osped Papa Giovanni XXIII, Bergamo, Italy

[2] Ist Nazl Tumori, I-20133 Milan, Italy

[3] Osped San Giovanni Battista Torino, Turin, Italy

[4] Policlin San Matteo, I-27100 Pavia, Italy

[5] AO Univ Udine, Udine, Italy

[6] Osped Maggiore Policlin, Milan, Italy

[7] Ist Clin Humanitas, Milan, Italy

[8] AO Santa Croce & Carle, Cuneo, Italy

[9] Policlin Gemelli, Rome, Italy

[10] Osped Civile, Pescara, Italy

[11] AO SS Antonio & Biagio & C Arrigo, Alessandria, Italy

[12] Univ Roma La Sapienza, Rome, Italy

[13] Osped Galliera, Genoa, Italy

[14] Ist Mario Negri Sud, Santa Maria Imbaro, Italy

[15] Osped San Martino Genova, Genoa, Italy

[16] Osped Careggi, Florence, Italy

来源：

BONE MARROW TRANSPLANTATION | 2013年 / 48卷

关键词：

D O I：

暂无

中图分类号：

Q6 [生物物理学];

学科分类号：

071011 ;

摘要：

引用

页码：S60 / S61

页数：2

共 50 条

[1] In Vivo T Cell Depletion with Antithymocyte Globulin or Alemtuzumab for Unrelated Donor Stem Cell Transplantation with Reduced Intensity Conditioning: Results of a Multicenter Randomized Phase II Clinical Trial (The Global Study) From the Gruppo Italiano Trapianto Di Midollo Osseo (GITMO)
Rambaldi, Alessandro
Algarotti, Alessandra
Mico, Caterina
Corradini, Paolo
Falda, Michele
Alessandrino, Emilio Paolo
Fanin, Renato
Tagliaferri, Elena
Castagna, Luca
Mordini, Nicola
Sica, Simona
Santarone, Stella
Pini, Massimo
Natalino, Fiammetta
Pollichieni, Simona
Sacchi, Nicoletta
Scarano, Marco
Masciulli, Arianna
Marchioli, Roberto
Bacigalupo, Andrea
Bosi, Alberto
BLOOD, 2012, 120 (21)
[2] Outcomes after myeloablative unrelated donor stem cell transplantation using both in vitro and in vivo T-cell depletion with alemtuzumab
von Dem Borne, Peter A.
Beaumont, Floor
Starrenburg, C. W. J. Ingrid
Oudshoorn, Machteld
Hale, Geoff
Falkenburg, J. H. Frederik
Fibbe, Willem E.
Willemze, Roel
Barge, Renee M. Y.
HAEMATOLOGICA, 2006, 91 (11) : 1559 - 1562
[3] Reduced-intensity conditioning regimen with ex vivo T-cell depletion after unrelated donor as stem cell source for patients with haematological malignancies
Castagna, L.
Crocchiolo, R.
Furst, S.
El Cheikh, J.
Esterni, B.
Granata, A.
Lemarie, C.
Oudin, C.
Faucher, C.
Chabannon, C.
Blaise, D.
BONE MARROW TRANSPLANTATION, 2011, 46 : S329 - S329
[4] In vitro and in vivo T-cell depletion with myeloablative or reduced-intensity conditioning in pediatric hematopoietic stem cell transplantation
Seidel, Markus G.
Fritsch, Gerhard
Matthes-Martin, Susanne
Lawitschka, Anita
Lion, Thomas
Poetschger, Ulrike
Rosenmayr, Agathe
Fischer, Gottfried
Gadner, Helmut
Peters, Christina
HAEMATOLOGICA, 2005, 90 (10) : 1405 - 1414
[5] Clinical effect of reduced-intensity conditioning regimen containing antithymocyte globulin for hematopoietic cell transplantation from unrelated-donors
Lee, Kyoo-Hyung
Choi, Seong-Jun
Lee, Je-Hwan
Lee, Jung-Hee
Kim, Dae-Young
Seol, Miee
Lee, Young-Shin
Kang, Young-Ah
Jeon, Mijin
Yun, Sung-Cheol
Joo, Young-Don
Lee, Won-Sik
Kang, Myoung-Joo
Kim, Hawk
Park, Jae-Hoo
Bae, Sung-Hwa
Ryoo, Hun-Mo
Kim, Min-Kyoung
Hyun, Myung-Soo
AMERICAN JOURNAL OF HEMATOLOGY, 2011, 86 (05) : 399 - 405
[6] Impact of In Vivo T-Cell Depletion on Outcome of Reduced Intensity Conditioning (RIC) Hematopoietic Cell Transplantation (HCT) for Hematologic Malignanciesimpact of In Vivo T-Cell Depletion on Outcome of Reduced Intensity Conditioning (RIC) Hematopoietic Cell Transplantation (HCT) for Hematologic Malignancies
Soiffer, Robert J.
LeRademacher, Jennifer
Ho, Vincent T.
Kan, Fangyu
Artz, Andrew
Champlin, Richard
Devine, Steven
Lazarus, Hillard M.
Marks, David I.
Porter, David
Waller, Edmund K.
Horowitz, Mary M.
Eapen, Mary
BLOOD, 2010, 116 (21) : 951 - 952
[7] Hematopoietic Cell Transplantation from an HLA-Mismatched Familial Donor Is Feasible Without Ex Vivo-T Cell Depletion after Reduced-intensity Conditioning with Busulfan, Fludarabine, and Antithymocyte Globulin
Lee, Kyoo-Hyung
Lee, Je-Hwan
Lee, Jung-Hee
Kim, Dae-Young
Kim, Se-Hyung
Shin, Ho-Jin
Lee, Young-Shin
Kang, Young-Ah
Seol, Miee
Ryu, Sung-Gil
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2009, 15 (01) : 61 - 72
[8] IN VIVO T-CELL DEPLETION WITH LOW-DOSE ANTITHYMOCYTE GLOBULIN TO REDUCE ACUTE GVHD IN UNRELATED DONOR STEM CELL TRANSPLANT FOR PATIENTS WITH SEVERE APLASTIC ANEMIA
Lee, S.
Yoon, J.
Shin, S.
Yahng, S.
Cho, B.
Eom, K.
Kim, Y.
Lee, S.
Min, C.
Kim, H.
Cho, S.
Kim, D.
Min, W.
Park, C.
Lee, J.
HAEMATOLOGICA, 2013, 98 : 380 - 381
[9] Impact Of Female Donor On Allogeneic Stem Cell Transplantation Outcome Of Male Recipient After T-Cell Depletion By Rabbit Antithymocyte Globulin
Calmettes, Claire
Vigouroux, Stephane
Tabrizi, Reza
Pigneux, Arnaud
Leguay, Thibaut
Bouabdallah, Krimo
Dilhuydy, Marie-Sarah
Duclos, Cedric
Lascaux, Axelle
Dumas, Pierre-Yves
Dimicoli-Salazar, Sophie
Marit, Gerald
Milpied, Noel
BLOOD, 2013, 122 (21)
[10] IMPACT OF FEMALE DONOR ON ALLOGENEIC STEM CELL TRANSPLANTATION OUTCOME OF MALE RECIPIENT AFTER T-CELL DEPLETION BY RABBIT ANTITHYMOCYTE GLOBULIN
Calmettes, C.
Vigouroux, S.
Tabrizi, R.
Pigneux, A.
Leguay, T.
Bouabdallah, K.
Dilhuydy, M. -S.
Duclos, C.
Lascaux, A.
Dumas, P. -Y.
Dimicoli-Salazar, S.
Marit, G.
Milpied, N.
BONE MARROW TRANSPLANTATION, 2014, 49 : S281 - S282

← 1 2 3 4 5 →